搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
clinicaltrialsarena
1 天
Arrowhead doses first patient in Phase I/IIa RNA obesity therapy trial
The investigational therapy works to impede the expression of genes that cause the body to store fat as a potential treatment for obesity.
clinicaltrialsarena
1 天
XBiotech halts all rheumatology research after missing Phase II endpoints
XBiotech has said it will investigate the results of its rheumatoid arthritis trial after finding irregularities in its Phase II trial.
clinicaltrialsarena
1 天
Zura Bio initiates Phase II systemic sclerosis treatment trial
Zura Bio has initiated the Phase II TibuSURE trial to assess tibulizumab, in treating systemic sclerosis (SSc) in adult patients.
clinicaltrialsarena
2 天
First patient dosed as Marengo’s invikafusp alfa trial expands to Europe
Marengo's Phase II trial is assessing T cell activator invikafusp alfa in the treatment of advanced PD-1 resistant solid tumours.
clinicaltrialsarena
2 天
2024: record year for AI trials
AI continued to be shown as an invaluable tool with the potential to accelerate clinical trials and improve patient care.
clinicaltrialsarena
2 天
BMS sees success in Phase III Sotyktu psoriatic arthritis trials
Both trials recruited patients with psoriatic arthritis who had not previously received biologic disease-modifying antirheumatic drugs.
clinicaltrialsarena
3 天
Most significant clincal trials of 2024
There have been several impactful clinical trial read outs in 2024. Image credit: Shutterstock / Rajitha Tennakoon From gene therapies to psychedelics and cancer vaccines to HIV pre-exposure ...
clinicaltrialsarena
2 天
JCR Pharmaceuticals doses first patient in paediatric growth hormone trial
The Phase III trial is set to use growth outcomes as its primary endpoint in the 52-week trial of JR-142, a long-acting growth hormone.
clinicaltrialsarena
12 天
Trevi’s chronic cough trial in IPF subjects continues without sample size change
Trevi has announced that its Phase IIb trial of Haduvio in treating IPF subjects with chronic cough will continue without sample size change.
clinicaltrialsarena
5 天
Adicet Bio doses first subject in Phase I trial of renal cell carcinoma therapy
Adicet Bio has dosed the first subject in a multicentre Phase I trial of ADI-270, a gamma delta CAR T-cell therapy for treating ccRCC.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈